• Home
  • About
  • ‘Enforcement 40’ for 2020
  • Webcasts
  • Enforcement Hall of Fame
  • Contact
Securities Docket
Ankura 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2020 / April / 22 / If Top Exec Has Covid-19, Does the Company Have to Disclose It? | The D&O Diary

If Top Exec Has Covid-19, Does the Company Have to Disclose It? | The D&O Diary

By Securities Docket on April 22, 2020, 9:15 am

As the coronavirus outbreak has spread, the COVID-19 disease has struck millions across the globe. The demographics and geographic distribution of the disease will make for interesting study when the current outbreak has ended, but clearly the disease has struck both the mighty and modest. The high-profile victims include the Prince of Wales and the U.K. Prime Minister. Other victims have included (and likely will continue to include) senior corporate executives. When key execs contract the disease, their companies face the question whether the executives’ illness must be disclosed.  As discussed in Judy Greenwald’s April 21, 2020 Business Insurance article (here), there are no bright line answers to this question.

via If Top Exec Has Covid-19, Does the Company Have to Disclose It? | The D&O Diary.

Blog Widget by LinkWithin

Posted in SEC, Top | Tagged COVID-19

« Previous Next »

Subscribe

‘Enforcement 40’ for 2020

Securities-Docket_Medium-Rectangle_CaseStudyArrow

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2022 Securities Docket.

Powered by WordPress and Hybrid.